Compounds > 3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid
Page last updated: 2024-08-26

3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid and dronabinol

3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid has been researched along with dronabinol in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kompanje, EJ; Maas, AI; Murray, GD; Ohman, J; Slieker, FJ; Stocchetti, N; Teasdale, SG1

Trials

1 trial(s) available for 3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid and dronabinol

ArticleYear
Importance of screening logs in clinical trials for severe traumatic brain injury.
    Neurosurgery, 2008, Volume: 62, Issue:6

    Topics: Adolescent; Adult; Aged; Brain Injuries; Dronabinol; Feasibility Studies; Forms and Records Control; Humans; Medical Records; Middle Aged; Neuroprotective Agents; Outcome Assessment, Health Care; Patient Selection; Piperazines

2008